Detalles de la búsqueda
1.
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers.
Oncologist
; 25(7): 598-608, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32310325
2.
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
Oncologist
; 22(3): 343-350, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209748
3.
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.
Oncologist
; 21(12): 1522-1529, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27511906
4.
Personal Social Networks and Care-Seeking for Head and Neck Cancer: A Qualitative Study.
Otolaryngol Head Neck Surg
; 170(2): 457-467, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079157
5.
Perspectives on Referral Pathways for Timely Head and Neck Cancer Care.
JAMA Otolaryngol Head Neck Surg
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38753343
6.
Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma.
Front Oncol
; 14: 1395978, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38812776
7.
Patient Experience of Head and Neck Surgery With Free Flap Reconstruction.
JAMA Otolaryngol Head Neck Surg
; 150(4): 311-317, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386356
8.
Personalized circulating tumor DNA for monitoring disease status in head and neck squamous cell carcinoma.
Clin Cancer Res
; 2024 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38824449
9.
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.
JAMA Oncol
; 10(1): 32-41, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37971722
10.
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
Sci Immunol
; 8(87): eadf4968, 2023 09 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37683037
11.
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
Oncologist
; 22(11): 1413, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29123016
12.
Accuracy and outcomes of virtual surgical planning and 3D-printed guides for osseous free flap reconstruction of mandibular osteoradionecrosis.
Oral Oncol
; 135: 106239, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384079
13.
Virtual planning and 3D-printed guides for mandibular reconstruction: Factors impacting accuracy.
Laryngoscope Investig Otolaryngol
; 7(6): 1798-1807, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36544971
14.
Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
Head Neck
; 44(6): 1442-1452, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355358
15.
Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
JAMA Otolaryngol Head Neck Surg
; 148(12): 1120-1130, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36301568
16.
Assessment of Preoperative Functional Status Prior to Major Head and Neck Surgery: A Pilot Study.
Otolaryngol Head Neck Surg
; 166(4): 688-695, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34154446
17.
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.
Clin Cancer Res
; 28(3): 468-478, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34667025
18.
Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
Oral Oncol
; 112: 105087, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33190021
19.
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
JAMA Oncol
; 6(10): 1563-1570, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852531
20.
IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.
Head Neck
; 41(4): 959-966, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30620435